Scripps secures DIRECTV retransmission deal, third major MVPD renewal in 2026

What happened

E.W. Scripps announced a new retransmission consent agreement with DIRECTV, completing its three largest cable and satellite distribution deals for the year. While the company frames this as a positive step, it merely maintains the status quo for its pressured distribution revenue stream, which has been flat to slightly down as subscriber losses offset rate increases. The deal comes amid Scripps' ongoing efforts to deleverage and improve cash flow, with net leverage at ~4.6x and high interest costs. However, the real catalysts remain the 2026 political cycle and connected-TV growth, which are far more consequential for equity value. The retransmission agreement does little to change the fundamental equation: Scripps remains a highly leveraged bet on cyclical advertising and strategic M&A optionality.

Implication

For investors, the retransmission agreement confirms that Scripps can maintain its MVPD relationships, but it does not solve the structural pressure on distribution revenue as cord-cutting persists. The primary driver of near-term value remains the 2026 political advertising windfall, which must be used for debt reduction to improve the balance sheet. Without a meaningful improvement in non-political cash flow, the equity remains a high-risk, event-driven play. The deal also supports the M&A narrative by demonstrating that Scripps' distribution assets are still valued by partners, but the family-controlled poison pill and super-voting shares cap any immediate transaction premium. We see limited upside from here unless the company shows accelerating CTV growth and leverage falling below 4x.

Thesis delta

The retransmission deal is incremental positive but does not move the needle on our base-case valuation of $5.00, which already assumes stable distribution revenue. Our thesis remains anchored to the 2026 political cycle and Scripps Networks' margin durability; the DIRECTV renewal provides modest downside support but no catalyst for re-rating. We continue to rate SSP as a WAIT, with an attractive entry near $3.00 and a trim level above $5.50.